116 related articles for article (PubMed ID: 15664834)
1. Pyrrolidinohydroquinazolines--a novel class of CCR3 modulators.
Anderskewitz R; Bauer R; Bodenbach G; Gester D; Gramlich B; Morschhäuser G; Birke FW
Bioorg Med Chem Lett; 2005 Feb; 15(3):669-73. PubMed ID: 15664834
[TBL] [Abstract][Full Text] [Related]
2. N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists.
Batt DG; Houghton GC; Roderick J; Santella JB; Wacker DA; Welch PK; Orlovsky YI; Wadman EA; Trzaskos JM; Davies P; Decicco CP; Carter PH
Bioorg Med Chem Lett; 2005 Feb; 15(3):787-91. PubMed ID: 15664858
[TBL] [Abstract][Full Text] [Related]
3. The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: antagonists versus agonists.
Ting PC; Umland SP; Aslanian R; Cao J; Garlisi CG; Huang Y; Jakway J; Liu Z; Shah H; Tian F; Wan Y; Shih NY
Bioorg Med Chem Lett; 2005 Jun; 15(12):3020-3. PubMed ID: 15908209
[TBL] [Abstract][Full Text] [Related]
4. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
[TBL] [Abstract][Full Text] [Related]
5. High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells.
Parody TR; Stone MJ
Cytokine; 2004 Jul; 27(1):38-46. PubMed ID: 15207250
[TBL] [Abstract][Full Text] [Related]
6. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
Manns J; Rieder S; Escher S; Eilers B; Forssmann WG; Elsner J; Forssmann U
Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
[TBL] [Abstract][Full Text] [Related]
7. Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration.
White JR; Lee JM; Dede K; Imburgia CS; Jurewicz AJ; Chan G; Fornwald JA; Dhanak D; Christmann LT; Darcy MG; Widdowson KL; Foley JJ; Schmidt DB; Sarau HM
J Biol Chem; 2000 Nov; 275(47):36626-31. PubMed ID: 10969084
[TBL] [Abstract][Full Text] [Related]
8. Proteoglycans are potent modulators of the biological responses of eosinophils to chemokines.
Culley FJ; Fadlon EJ; Kirchem A; Williams TJ; Jose PJ; Pease JE
Eur J Immunol; 2003 May; 33(5):1302-10. PubMed ID: 12731055
[TBL] [Abstract][Full Text] [Related]
9. A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.
Suzuki K; Morokata T; Morihira K; Sato I; Takizawa S; Kaneko M; Takahashi K; Shimizu Y
Eur J Pharmacol; 2007 Jun; 563(1-3):224-32. PubMed ID: 17336292
[TBL] [Abstract][Full Text] [Related]
10. Bertilimumab Cambridge Antibody Technology Group.
Ding C; Li J; Zhang X
Curr Opin Investig Drugs; 2004 Nov; 5(11):1213-8. PubMed ID: 15573873
[TBL] [Abstract][Full Text] [Related]
11. Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency.
De Lucca GV; Kim UT; Vargo BJ; Duncia JV; Santella JB; Gardner DS; Zheng C; Liauw A; Wang Z; Emmett G; Wacker DA; Welch PK; Covington M; Stowell NC; Wadman EA; Das AM; Davies P; Yeleswaram S; Graden DM; Solomon KA; Newton RC; Trainor GL; Decicco CP; Ko SS
J Med Chem; 2005 Mar; 48(6):2194-211. PubMed ID: 15771462
[TBL] [Abstract][Full Text] [Related]
12. Eotaxin and asthma.
Pease JE; Williams TJ
Curr Opin Pharmacol; 2001 Jun; 1(3):248-53. PubMed ID: 11712747
[TBL] [Abstract][Full Text] [Related]
13. A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.
Sabroe I; Peck MJ; Van Keulen BJ; Jorritsma A; Simmons G; Clapham PR; Williams TJ; Pease JE
J Biol Chem; 2000 Aug; 275(34):25985-92. PubMed ID: 10854442
[TBL] [Abstract][Full Text] [Related]
14. Small molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation.
Wise EL; Duchesnes C; da Fonseca PC; Allen RA; Williams TJ; Pease JE
J Biol Chem; 2007 Sep; 282(38):27935-43. PubMed ID: 17635911
[TBL] [Abstract][Full Text] [Related]
15. Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines.
Duchesnes CE; Murphy PM; Williams TJ; Pease JE
Mol Immunol; 2006 Mar; 43(8):1221-31. PubMed ID: 16102831
[TBL] [Abstract][Full Text] [Related]
16. The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts.
Puxeddu I; Bader R; Piliponsky AM; Reich R; Levi-Schaffer F; Berkman N
J Allergy Clin Immunol; 2006 Jan; 117(1):103-10. PubMed ID: 16387592
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel CCR3 selective antagonist.
Naya A; Kobayashi K; Ishikawa M; Ohwaki K; Saeki T; Noguchi K; Ohtake N
Bioorg Med Chem Lett; 2001 May; 11(9):1219-23. PubMed ID: 11354381
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
Elsner J; Escher SE; Forssmann U
Allergy; 2004 Dec; 59(12):1243-58. PubMed ID: 15507091
[TBL] [Abstract][Full Text] [Related]
19. The CC chemokine receptor 3 CCR3 is functionally expressed on eosinophils but not on neutrophils.
Höchstetter R; Dobos G; Kimmig D; Dulkys Y; Kapp A; Elsner J
Eur J Immunol; 2000 Oct; 30(10):2759-64. PubMed ID: 11069055
[TBL] [Abstract][Full Text] [Related]
20. The carboxyl terminus of the chemokine receptor CCR3 contains distinct domains which regulate chemotactic signaling and receptor down-regulation in a ligand-dependent manner.
Sabroe I; Jorritsma A; Stubbs VE; Xanthou G; Jopling LA; Ponath PD; Williams TJ; Murphy PM; Pease JE
Eur J Immunol; 2005 Apr; 35(4):1301-10. PubMed ID: 15739168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
